Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neuro-Oncology

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1023/A:1015735815111PMID 12125964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of the multidrug-resistance P-glycoprotein (Pgp, MDR-1) by endothelial cells of the neovasculature in central nervous system tumors

  2006cited by this paper
• Ultrastructural localization of P-glycoprotein on capillary endothelial cells in human gliomas

  2004cited by this paper
• Uptake of drugs and expression of P-glycoprotein in the rat 9L glioma

  2004influential reference
• Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms.

  2001cited by this paper
• Anticancer drug resistance in primary human brain tumors.

  2001influential reference
• Expression of multidrug‐resistance P‐glycoprotein (MDR1) in human brain tumors

  2001cited by this paper
• The blood-brain barrier and oncology: new insights into function and modulation.

  2000influential reference
• Functional expression of p‐glycoprotein and multidrug resistance‐associated protein (mrp1) in primary cultures of rat astrocytes

  2000cited by this paper
• Biology and treatment of malignant glioma.

  2000cited by this paper
• Multidrug resistance transporters and modulation

  2000cited by this paper
• Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo

  2000cited by this paper
• Expression of Multidrug Resistance-associated Protein (MRP) in Human Gliomas

  2000cited by this paper
• Expression of the major vault protein LRP in human non‐small‐cell lung cancer cells: Activation by short‐term exposure to antineoplastic drugs

  2000influential reference
• Brain Microvascular P-Glycoprotein and a Revised Model of Multidrug Resistance in Brain

  2000cited by this paper
• Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells.

  2000cited by this paper
• Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma?

  1999cited by this paper
• Expression of multidrug resistance protein gene in patients with glioma after chemotherapy.

  1998cited by this paper
• Principles of treatment of malignant gliomas in adults: an overview.

  1998cited by this paper
• Immunohistochemical expression of P-glycoprotein and glutathione S-transferases in cerebral gliomas and response to chemotherapy

  1997cited by this paper
• Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells.

  1997cited by this paper
• Possible role of the multidrug resistance‐associated protein (MRP) in chemoresistance of human melanoma cells

  1997influential reference
• MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors.

  1996cited by this paper
• Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells

  1996cited by this paper
• P-glycoprotein and multidrug resistance.

  1996cited by this paper
• Possible involvement of multidrug‐resistance‐associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells

  1994cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• P-glycoprotein and multidrug resistance.

  1990cited by this paper
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.

  1989cited by this paper

• Tirabrutinib–anthracycline interactions in the brain tumor microenvironment: a focus on metabolic inactivation and resistance

  2025cites this paper
• Overcoming barriers and shaping the future: Challenges and innovations in nucleic acid therapies for Glioblastoma.

  2025cites this paper
• Advanced Noninvasive Strategies for the Brain Delivery of Therapeutic Proteins and Peptides.

  2024cites this paper
• Targeted Glioma Therapy—Clinical Trials and Future Directions

  2024cites this paper
• ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery

  2023cites this paper
• Modulation of Multidrug Resistance Protein 1-mediated Transport Processes by the Antiviral Drug Ritonavir in Cultured Primary Astrocytes

  2023cites this paper
• Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population

  2021cites this paper
• Efflux pumps, NHE1, monocarboxylate transporters, and ABC transporter subfamily inhibitors

  2021cites this paper
• The Role of Side Population Cells and Hypoxia in Resistance to Chemotherapy in Astrocytoma Cell Lines

  2021cites this paper
• Drug delivery and targeting to brain tumors: considerations for crossing the blood-brain barrier

  2021cites this paper
• Role of ATP-Binding Cassette Transporter Proteins in CNS tumors: Resistance-based perspectives and clinical updates.

  2020cites this paper
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019cites this paper
• ABC Transporters at the Blood–Brain Interfaces, Their Study Models, and Drug Delivery Implications in Gliomas

  2019influential citation
• Cytotoxicity of η6-areneruthenium-based molecules to glioblastoma cells and their recognition by multidrug ABC transporters.

  2018cites this paper
• Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.

  2018cites this paper
• Chapter 8 Liposomal Drug Delivery to the Central Nervous System

  2018cites this paper
• Neurosteroid Transport in the Brain: Role of ABC and SLC Transporters

  2018cites this paper
• Bioenergetic modulators hamper cancer cell viability and enhance response to chemotherapy

  2018cites this paper
• Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?

  2017cites this paper
• Reactive astrocytes increase the expression of P‑gp and Mrp1 via TNF‑α and NF‑κB signaling.

  2017cites this paper
• Microdialysis: the Key to Physiologically Based Model Prediction of Human CNS Target Site Concentrations

  2017cites this paper
• Liposomal Drug Delivery to the Central Nervous System

  2017cites this paper
• Connection between proliferation rate and temozolomide sensitivity of primary glioblastoma cell culture and expression of YB-1 and LRP/MVP

  2016cites this paper
• Membrane Transporters and Pharmacological Implications

  2016cites this paper
• Chemical approaches towards elucidating glioblastoma biology

  2016cites this paper
• Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance

  2016cites this paper
• MRP1 and its role in anticancer drug resistance

  2015influential citation
• Chemoresistance and chemotherapy targeting stem-like cells in malignant glioma.

  2015cites this paper
• Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletion

  2015cites this paper
• The Use of Anthracyclines for Therapy of CNS Tumors

  2015cites this paper
• In vitro testing to a panel of potential chemotherapeutics and current concepts of chemotherapy in benign meningiomas.

  2015cites this paper
• Mechanisms of regulation of P-glycoprotein and breast cancer resistance protein at the blood-brain barrier : focus on the role of morphine, and P-glycoprotein activation

  2015cites this paper
• Single-Cell Western Blotting after Whole-Cell Imaging to Assess Cancer Chemotherapeutic Response

  2014cites this paper
• Comparison of 99mTc-Tetrofosmin and 99mTc-Sestamibi Uptake in Glioma Cell Lines: The Role of P-Glycoprotein Expression

  2014cites this paper
• Why electroporation is a useful technique for cancer treatments

  2014cites this paper
• Functional expression of drug transporters in glial cells: potential role on drug delivery to the CNS.

  2014cites this paper
• Nanoparticle based strategies for the treatment of Glioblastoma

  2014cites this paper
• Effects of temozolomide (TMZ) on the expression and interaction of heat shock proteins (HSPs) and DNA repair proteins in human malignant glioma cells

  2014cites this paper
• Human ABC transporters at blood-CNS interfaces as determinants of CNS drug penetration.

  2014cites this paper
• Epithelial‐to‐mesenchymal transition is involved in BCNU resistance in human glioma cells

  2014cites this paper
• Calcium-channel blocking and nanoparticles-based drug delivery for treatment of drug-resistant human cancers.

  2014cites this paper
• Association between DNA methylation and multidrug resistance in human glioma SHG-44 cells

  2014cites this paper
• Drug resistance mechanisms in a high grade glioma cell line

  2013cites this paper
• Implications of Glioblastoma Stem Cells in Chemoresistance

  2013cites this paper
• New Advances on Disease Biomarkers and Molecular Targets in Biomedicine

  2013cites this paper
• Drug Transporters At Brain Barriers

  2013cites this paper
• Chemoresistance in Glioma

  2013influential citation
• Immunohistochemical study of MRP5 expression in meningiomas

  2013cites this paper
• Intercellular transfer of P-glycoprotein from the drug resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact.

  2013cites this paper
• A nanoliposome-based drug delivery system for cancer

  2013cites this paper
• Multidrug resistance: Physiological principles and nanomedical solutions.

  2013cites this paper
• Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms.

  2013cites this paper
• The role of AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system disease.

  2013cites this paper
• Transport and Metabolism at Blood–Brain Interfaces and in Neural Cells: Relevance to Bilirubin-Induced Encephalopathy

  2012cites this paper
• BILIRUBIN INTERACTIONS WITH METABOLIC/TRANSPORT PROCESSES AT THE BLOOD-BRAIN INTERFACES

  2012cites this paper
• Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.

  2012cites this paper
• MGMT hypermethylation and MDR system in glioblastoma cancer stem cells.

  2012cites this paper
• Prognostic significance of MRP5 immunohistochemical expression in glioblastoma

  2012cites this paper
• Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes.

  2012cites this paper
• Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells.

  2012cites this paper
• IMPROVING DELIVERY OF ELACRIDAR TO ENHANCE EFFICACY OF MOLECULARLY-TARGETED AGENTS IN TREATMENT OF GLIOBLASTOMA

  2012cites this paper
• In search of a novel target — Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy

  2011cites this paper
• Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine

  2011cites this paper
• Combined Use of Anticancer Drugs and an Inhibitor of Multiple Drug Resistance-Associated Protein-1 Increases Sensitivity and Decreases Survival of Glioblastoma Multiforme Cells In Vitro

  2011cites this paper
• Influence of Glioma's Multidrug Resistance Phenotype on 99mTc-Tetrofosmin Uptake

  2011cites this paper
• Genetic and molecular alterations in meningiomas.

  2011cites this paper
• Improving delivery of molecularly targeted agents to glioma

  2011cites this paper
• Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain

  2011cites this paper
• ABC transporters in the CNS - an inventory.

  2011cites this paper
• Anàlisi “ex vivo” de mecanismes d’inducció d’apoptosi i resistència al tractament en gliomes malignes

  2011cites this paper
• Sphingosine Kinase Mediates Resistance to the Synthetic Retinoid N-(4-Hydroxyphenyl)retinamide in Human Ovarian Cancer Cells*

  2010cites this paper
• Cyclodepsipeptides - potential drugs and lead compounds in the drug development process.

  2009cites this paper
• Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells.

  2008cites this paper
• Barrière hémato-encéphalique humaine et endothéline 1 : régulation des transporteurs ABC et des cytokines inflammatoires

  2008cites this paper
• Regulation of ABC membrane transporters in glial cells: Relevance to the pharmacotherapy of brain HIV‐1 infection

  2008cites this paper
• Differences in the Expression Pattern of P-Glycoprotein and MRP1 in Low-Grade and High-Grade Gliomas

  2008cites this paper
• Distribution of multidrug resistance associated proteins in different histological subtypes and stages in operable non small cell lung cancer. A tissue microarray study

  2008cites this paper
• Modulation of efflux pumps in tumour cells as a possible way of reversal multidrug resistance

  2008cites this paper
• Chemoresistance in gliomas

  2008influential citation
• Determination and modelling of stereoselective interactions of ligands with drug transporters: A key dimension in the understanding of drug disposition

  2008cites this paper
• Localization of P-glycoprotein at the nuclear envelope of rat brain cells.

  2007cites this paper
• Enniatin exerts p53-dependent cytostatic and p53-independent cytotoxic activities against human cancer cells.

  2007cites this paper
• Drug-resistance in central nervous system tumors: from the traditional cell-resistance model to the genetically driven approaches on therapy.

  2007cites this paper
• Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma

  2007cites this paper
• Insulin-like growth factor type I biology and targeting in malignant gliomas.

  2007cites this paper
• The role of membrane transporters in drug delivery to brain tumors.

  2007cites this paper
• Gefitinib accumulation in glioblastoma tissue

  2006cites this paper
• Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System

  2006cites this paper
• p53 and Multidrug Resistance Transporters in the Central Nervous System

  2006cites this paper
• Alternating current electrical stimulation enhanced chemotherapy: a novel strategy to bypass multidrug resistance in tumor cells

  2006cites this paper
• Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum

  2006cites this paper
• Role of ABC transporters in the chemoresistance of human gliomas.

  2006cites this paper
• ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier.

  2005cites this paper
• Expression of ABC-1 transporter is elevated in human glioma cells under irradiation and temozolomide treatment

  2005cites this paper
• Potentiation by alpha-tocopheryl succinate of the etoposide response in multidrug resistance protein 1-expressing glioblastoma cells.

  2005cites this paper
• Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma

  2005cites this paper
• Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

  2005cites this paper
• Drug delivery and in vitro models of the blood-brain barrier.

  2005cites this paper
• In vitro effects of topotecan and ionizing radiation on TRAIL/Apo2L-mediated apoptosis in malignant glioma

  2004cites this paper
• Brain endothelial cells as pharmacological targets in brain tumors

  2004cites this paper